Smart jab can shrink head and neck cancer tumours within six weeks, trial finds
Triple-action therapy drug amivantamab could be given as an injection to help treat recurrent or metastatic cancers Doctors have hailed “incredibly encouraging” trial results that show a triple-action smart jab can shrink tumours in head and neck cancer patients within six weeks. Head and neck (…)
Site référencé:
The Guardian
3566.jpg?width=140&quality=85&auto=format&fit=max&s=6b8d8aa1d243e52630ec912240d7c64f, 3566.jpg?width=460&quality=85&auto=format&fit=max&s=2d87713509e54a6825bcd7efa979683a, 3566.jpg?width=700&quality=85&auto=format&fit=max&s=0f55e3e23cd4fdddf1f92afd52d64c83
The Guardian
Experiential entertainment is having a gold rush but commercial success is far from certain
19/10/2025
What’s happening with Marjorie Taylor Greene ? Why the Maga loyalist has won some Democratic fans
19/10/2025
Dining across the divide : ‘We didn’t agree on immigration. She was almost conspiratorial’
19/10/2025
‘A kind of therapy’ : scream club brings Londoners together to ‘let it all out’
19/10/2025
This is how we do it : ‘When I tell other gay men we’re monogamous, it’s like I’ve said we have a strange kink’
19/10/2025
Nottingham Forest make Marco Silva their No 1 target to replace Postecoglou
19/10/2025